Hong Kong, China vs Mongolia: HIV-positive TB patients on ART (antiretroviral therapy)
Hong Kong, China
100.0%
in 2024
Mongolia
100.0%
in 2024
Hong Kong, China rank
1st
Mongolia rank
1st
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Hong Kong, China
- Mongolia
How they compare
Hong Kong, China currently reports 100.0% against 100.0% in Mongolia, a difference of 0.0%.
The two have swapped places 2 times across 14 shared years of data; in 2005 it was Mongolia ahead.
Hong Kong, China ranks 1st and Mongolia ranks 1st of 144 countries.
Mongolia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Hong Kong, China | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 49.5% | 83.2% | 33.8% | Mongolia |
| 2010s | 31.1% | 85.2% | 54.1% | Mongolia |
| 2020s | 93.5% | 100.0% | 6.5% | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Hong Kong, China or Mongolia?
- Hong Kong, China, at 100.0% against 100.0% in Mongolia as of 2024.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Hong Kong, China and Mongolia?
- 0.0%, with Hong Kong, China ahead.
- How many years of comparable data are there for Hong Kong, China and Mongolia?
- 14 years are reported by both, from 2005 to 2024.
- How do Hong Kong, China and Mongolia rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Hong Kong, China ranks 1st and Mongolia ranks 1st of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.